MARTINGALE ASSET MANAGEMENT L P - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARTINGALE ASSET MANAGEMENT L P ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$636,583
+10.6%
14,0340.0%0.01%
+18.2%
Q2 2023$575,816
+15.6%
14,034
+0.7%
0.01%
+10.0%
Q1 2023$498,324
+27.3%
13,943
+34.6%
0.01%
+25.0%
Q4 2022$391,336
-9.2%
10,361
+6.7%
0.01%
-11.1%
Q3 2022$431,000
+56.7%
9,713
+31.2%
0.01%
+80.0%
Q2 2022$275,0000.0%7,4050.0%0.01%
+25.0%
Q1 2022$275,0007,4050.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders